Journal Article Review Research Support, Non-U.S. Gov't Epublish 6 citations
PubMed: 38264667 DOI: 10.3389/fimmu.2023.1307228
Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy.
Front Immunol 14:1307228
Authors: Yanru Long, Houhui Shi, Yuedong He, Xiaorong Qi
Affiliations
- Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China.
Abstract
Tumor metabolism and tumor immunity are inextricably linked. Targeting the metabolism of tumors is a point worth studying in tumor immunotherapy. Recently, the influence of the metabolism of tumors and immune cells on the occurrence, proliferation, metastasis, and prognosis of tumors has attracted more attention. Tumor tissue forms a specific tumor microenvironment (TME). In addition to tumor cells, there are also immune cells, stromal cells, and other cells in TME. To adapt to the environment, tumor cells go through the metabolism reprogramming of various substances. The metabolism reprogramming of tumor cells may further affect the formation of the tumor microenvironment and the function of a variety of cells, especially immune cells, eventually promoting tumor development. Therefore, it is necessary to study the metabolism of tumor cells and its effects on immune cells to guide tumor immunotherapy. Inhibiting tumor metabolism may restore immune balance and promote the immune response in tumors. This article will describe glucose metabolism, lipid metabolism, amino acid metabolism, and immune cells in tumors. Besides, the impact of metabolism on the immune cells in TME is also discussed for analyzing and exploring tumor immunotherapy.
MeSH
Cells, Neoplasms, Immunotherapy, Immune System Diseases, Immunity, Stromal Cells, Environment, Tumor Microenvironment
Cited by
- Non-histone lactylation: unveiling its functional significance. Front Cell Dev Biol, 2025
- Design of pH-Responsive Nanomaterials Based on the Tumor Microenvironment. Int J Nanomedicine, 2025
- is a metabolic checkpoint in triple-negative breast cancer: Insights from multiple omics analysis and experiments. Mol Ther Oncol, 2025
- Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies. Front Immunol, 2025